Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Vakoc

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Trends in Cell Biology|October 8, 2014
Brd4 is on the move during inflammationYali Xu, Christopher R Vakoc
Briefings in Functional Genomics|June 2, 2012
WRAD: enabler of the SET1-family of H3K4 methyltransferasesPatricia Ernst, Christopher R Vakoc
Current Opinion in Genetics & Development|February 24, 2024
Therapeutic index of targeting select chromatin complexes in human cancer patientsYuan Gao, Christopher R Vakoc
Cold Spring Harbor Perspectives in Medicine|February 19, 2017
Targeting Cancer Cells with BET Bromodomain InhibitorsYali Xu, Christopher R Vakoc
Molecular Cell|June 7, 2014
The mechanisms behind the therapeutic activity of BET bromodomain inhibitionJunwei Shi, Christopher R Vakoc
Current Opinion in Oncology|November 18, 2014
Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic interventionChen Shen, Christopher R Vakoc
Molecular Cell|March 25, 2014
A new bump in the epigenetic landscapeAnand S Bhagwat, Christopher R Vakoc
Cold Spring Harbor Symposia on Quantitative Biology|February 9, 2017
The Essential Transcriptional Function of BRD4 in Acute Myeloid LeukemiaJae-Seok Roe, Christopher R Vakoc
Cancer Cell|June 15, 2010
PAF is in the cabal of MLL1-interacting proteins that promote leukemiaNancy A Speck, Christopher R Vakoc
Trends in Genetics : TIG|June 17, 2014
A rationale to target the SWI/SNF complex for cancer therapyAnja F Hohmann, Christopher R Vakoc
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Trends in Cell Biology|October 8, 2014
Brd4 is on the move during inflammationYali Xu, Christopher R Vakoc
Briefings in Functional Genomics|June 2, 2012
WRAD: enabler of the SET1-family of H3K4 methyltransferasesPatricia Ernst, Christopher R Vakoc
Current Opinion in Genetics & Development|February 24, 2024
Therapeutic index of targeting select chromatin complexes in human cancer patientsYuan Gao, Christopher R Vakoc
Cold Spring Harbor Perspectives in Medicine|February 19, 2017
Targeting Cancer Cells with BET Bromodomain InhibitorsYali Xu, Christopher R Vakoc
Molecular Cell|June 7, 2014
The mechanisms behind the therapeutic activity of BET bromodomain inhibitionJunwei Shi, Christopher R Vakoc
Current Opinion in Oncology|November 18, 2014
Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic interventionChen Shen, Christopher R Vakoc
Molecular Cell|March 25, 2014
A new bump in the epigenetic landscapeAnand S Bhagwat, Christopher R Vakoc
Cold Spring Harbor Symposia on Quantitative Biology|February 9, 2017
The Essential Transcriptional Function of BRD4 in Acute Myeloid LeukemiaJae-Seok Roe, Christopher R Vakoc
Cancer Cell|June 15, 2010
PAF is in the cabal of MLL1-interacting proteins that promote leukemiaNancy A Speck, Christopher R Vakoc
Trends in Genetics : TIG|June 17, 2014
A rationale to target the SWI/SNF complex for cancer therapyAnja F Hohmann, Christopher R Vakoc
Pageof 14